Tamiflu And Relenza Should Have Psychiatric Side Effects Warning, Say Regulators
Tamiflu And Relenza Should Have Psychiatric Side Effects Warning, Say Regulators
|
After receiving reports of patients experiencing delirium, psychosis and hallucinations, US FDA staff recommend that flu drugs, Tamiflu and Relenza should carry warnings about possible side-effects. Tamiflu is made by Roche Holdings, Relenza is made by GSK (GlaxoSmithKline). Tamiflu (oseltamivir) is a pill, while Relenza (zanamivir) is inhaled. [click link for full article] |
read more...
News entry number 3590 added on Nov 25, 2007 in the Health category.
Comenteaza
Other News in the Health category
Categorie:
2. New York Methodist Hospital Set To Begin A Clinical Trial That May Help Emphysema Sufferers Breathe
Categorie:
Categorie:
Categorie:
Categorie:
Related Links
- An email conversation with Trevor Sinclair: 'I didn't have a Plan B. If I hadn't made it, I'd have s
- Bush Should Call On Congress To Reduce PEPFAR Funding In Reauthorization Legislation, Opinion Piece
- Schwarzenegger pressing state regulators to allow power line proposed through Anza-Borrego Desert St
- Rory Lamont: 'I've got to stay at the top of my game. As soon as I have a bad game I'll be dropped'
- Start Of Football Season Means Sports Medicine Physicians Should Brace Themselves For Injuries
- Sleep Treatment Often Denied To Insomnia Patients When They Have Mental Health Conditions
- GPhA: E-Pedigree System Should Be Risk-Based, Workable And Patient-Focused
- Kids in affluent countries more likely to have allergy-induced asthma: study
- Yankees 12, Orioles 0: Boston Series Behind Them, Yankees Have Sox in Sight
News Categories
745
523
480
347
1011
693
280
973
Top 10 News
- Texas Woman Claims to Have Found Mythical 'Chupacabra'
- Google Starts Hosting News on Website
- Wireless technology hits security budgets
- Google forced to push image in China
- Western School Board limits digital devices
- 'Spooky' science points to quantum internet
- Nuñez, gov. gamble on healthcare overhaul
- Ho-hum, the guest's another candidate
- Study Focuses On Cancer Risk In Biologic Treatment For Rheumatoid Arthritis
- Microsoft purchase of RIM nice to consider, but unlikely
Statistics
News:
News Categories:
News Read:
News Categories:
News Read:
5052
8
610
8
610